A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma
Lung adenocarcinoma (LUAD) has become the most prevalent histologic subset of primary lung cancer, and effective innovative prognostic models are needed to enhance the feasibility of targeted therapies for the disease. Programmed cell death (PCD) performs an integral function in the origin and treat...
Main Authors: | Huizhe Zhang, Yanchen Shi, Qing Yi, Cong Wang, Qingqing Xia, Yufeng Zhang, Weilong Jiang, Jia Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.975185/full |
Similar Items
-
A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma
by: Bixian Luo, et al.
Published: (2022-11-01) -
Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
by: Wentao Zhang, et al.
Published: (2023-08-01) -
Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
by: Yanju Lv, et al.
Published: (2022-10-01) -
Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma
by: Zihao Sun, et al.
Published: (2023-07-01) -
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
by: Gujie Wu, et al.
Published: (2023-03-01)